Virbac (Virbac) Total Stockholders Equity : $973 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Virbac Total Stockholders Equity?

Virbac's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $973 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Virbac's Book Value per Share for the quarter that ended in Jun. 2023 was $115.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Virbac's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.18.

Virbac Total Stockholders Equity Historical Data

The historical data trend for Virbac's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Total Stockholders Equity Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

523.67

575.31

755.43

819.14

889.13

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															843.02	819.14	866.48	889.13	973.48

Virbac (OTCPK:VRBCF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Virbac's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(973.48	-	0)	/	8.44306
	=	115.30

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Virbac's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(85.166	+	94.496)	/	973.48
	=	0.18

Virbac Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Virbac's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.